Ozempic Maker Novo Nordisk Is Plunging 20%. Time to Sell or Buy More?
Danish pharmaceutical giant Novo Nordisk (NYSE:NVO | NVO Price Prediction) is watching its stock plummet 20% in morning trading after slashing its full-year sales and profit outlook for the second time this…